This article is a commentary on:
Autonomic Modulation in Patients with Heart Failure Increases Beat-to-Beat Variability of Ventricular Action Potential Duration
Valerie Y. H. Van Weperen
Marc A. Vos
Marcel A. G. Van der Heyden- Department of Medical Physiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, Netherlands
A commentary on
Autonomic Modulation in Patients with Heart Failure Increases Beat-to-Beat Variability of Ventricular Action Potential Duration
by Porter, B., Bishop, M. J., Claridge, S., Behar, J., Sieniewicz, B. J., Webb, J., et al. (2017). Front. Physiol. 8:328. doi: 10.3389/fphys.2017.00328
Porter et al. (2017) recently published an interesting paper in which they explored the in vivo effect of the sympathetic nervous system (SNS) on cardiac electrophysiological stability. In their study, heart failure (HF) patients treated by cardiac resynchronization therapy (CRT) increased their sympathetic tone by performing the Valsalva maneuver. Comparison of the electrophysiological consequences of this stimulation on and off treatment with bisoprolol, allowed assessment of the effect of SNS stimulation. Their results demonstrated a significant 53% increase of the beat-to-beat variability of activation recovery intervals (ARIs) in absence of bisoprolol, whereas presence of bisoprolol restrained this increase to 11%.
For many decades, hyperactivity of the SNS has been identified as a factor in the development of arrhythmias (Schwartz, 2014; Shen and Zipes, 2014). In addition, surgical sympathetic denervation of the heart has long been established as an effective anti-arrhythmic therapy. The first stellectomy dates back to 1916, when Jonnesco employed the intervention and successfully freed a patient of angina pectoris and recurrent episodes of ventricular arrhythmias (Jonnesco, 1921). Successive research increasingly elucidated the distressing effects of the SNS on the heart and increasingly deciphered the causal relationship between activity of the SNS, especially that of the left stellate ganglion (Schwartz and Stone, 1980), and arrhythmogenesis (Zhou et al., 2008). However, these perturbing sympathetic effects resulting in ventricular arrhythmias are only present in abnormal cardiac conditions, as in HF and/or long QT-syndrome patients (Rubart and Zipes, 2005).
The extent of this pro-arrhythmic contribution can be evaluated by assessing the electrophysiological stability of the heart. Beat-to-beat variability of, for example, ventricular repolarization or ARIs is an indicator of cardiac electrophysiological stability (Thomsen et al., 2004; Varkevisser et al., 2012). Repolarization robustness may be quantified by the short-term variability (STV), a parameter that represents the average deviation of n number of consecutive beats from the line of identity in a Poincaré plot. The electrophysiological disturbances caused by pro-arrhythmic factors, e.g., through decreasing the repolarization reserve, will progressively increase the beat-to-beat variability and thus also the STV. In their study, Porter et al. assessed this parameter to explore the effects of beta blockade on electrophysiological stability. However, in contrast to the standard, and more robust, calculation of STV using 30 consecutive beats (Thomsen et al., 2005), Porter et al. based their results on the ARI of 10 consecutive beats, probably forced by the short duration of the effects of the Valsalva maneuver. Reasonably, the use of less beats allows outliers to have a disproportionate effect on the STV, possibly giving rise to an overestimation of the anti-arrhythmic efficacy of beta-blocking drugs. In addition, ARI based calculations of STV are highly dependent on the morphology of the ARI. Hence, temporal inconsistencies in its morphology, for example in electrophysiological instable and/or challenging situations, might translate to a decreased reliability of the calculated STV (Oosterhoff et al., 2010).
Furthermore, Porter et al. might have underestimated and/or overlooked the influence of non-electrophysiological parameters on the beat-to-beat variability. As previously determined by Stams et al. (2016) mechanical effects, such as fluctuating preload, may independently cause significant increases in STV. Since the Valsalva maneuver induces a substantial variability in preload, one could argue that the observed increase in STV could, to some extent, be ascribed to these mechanical effects.
Neuromodulation as an anti-arrhythmic therapy has however not advanced to the level that it is much implemented in the clinic. An explanation could be found in the lower anti-arrhythmic efficacy of neuromodulating drugs, such as beta blockers, in comparison to more effective surgical denervation. Although there are no studies on this discrepancy, several hypotheses have been suggested.
First, the utilization of drugs is accompanied by limiting factors such as safety issues, pharmacokinetic, and dynamic characteristics, but also drug refractoriness in patients. In addition, most neuromodulatory drugs block a smaller spectrum of sympathetic input than a stellectomy may achieve. For example (selective) beta-blockers such as bisoprolol, which was used in the paper of Porter et al. (2017), does not affect beta 2- as well as alpha-adrenergic receptors, thereby leading to incomplete removal of sympathetic effects on the myocardium.
Second, interference with the postganglionic transmission of sympathetic stimuli, as most drugs do, in general induces upregulation of adrenergic receptors causing increased sensitivity to agonists (Haeusler, 1990). This adverse effect may not occur after stellectomy (Schwartz and Stone, 1982). This critical difference in cardiac response to either form of denervation probably underlies the difference in efficacy of pharmacological and surgical denervation therapies.
It is thus through simple yet cogent reasoning that one has to conclude that sympathetic interference may present a potent, yet undervalued, anti-arrhythmic strategy. Cardiac sympathetic denervation has already proven itself to be an effective treatment against ventricular arrhythmias in patients. Achieving as equally successful results through pharmacological sympathetic blockade remains a challenge. As presented by Porter et al. (2017), though successfully reducing the beat-to-beat variability in ARI, the sympathetic effects were not fully eliminated. Careful analysis of studies reporting a possible anti-arrhythmic effect of neuromodulatory drugs, such as presented in the paper by Porter et al. (2017), might contribute to finding an explanation for the variable efficacy of pharmacological sympathetic blockades in disengaging the heart from its sympathetic influence. Therefore, the results of Porter et al. (2017), may be instrumental in the development of new pharmacological anti-arrhythmic therapies.
Author Contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Haeusler, G. (1990). Pharmacology of beta-blockers: classical aspects and recent developments. J. Cardiovasc. Pharmacol. 16, S1–S9. doi: 10.1097/00005344-199006165-00002
Jonnesco, T. (1921). Traitement chirurgical de l'angine de poitrine par la resection du sympathique cervico-thoracique. Presse Méd. 20, 221–230.
Oosterhoff, P., Thomsen, M. B., Maas, J. N., Atteveld, N. J. M., Beekman, J. D. M., van Rijen, H. V. M., et al. (2010). High rate pacing reduces variability of repolarization and prevents repolarization-dependent arrhythmias in dogs with chronic AV-block. J. Cardiovasc. Electrophysiol. 21, 1384–1391. doi: 10.1111/j.1540-8167.2010.01824.x
Porter, B., Bishop, M., Claridge, S., Behar, J., Sieniewicz, B., Webb, J., et al. (2017). Beat-to-beat variability of ventricular action potential duration is increased during autonomic modulation in patients with heart failure. Front. Physiol. 8:328. doi: 10.3389/fphys.2017.00328
Rubart, M., and Zipes, D. P. (2005). Mechanisms of sudden cardiac death. J. Clin. Invest. 115, 2305–2315. doi: 10.1172/JCI26381
Schwartz, P. J. (2014). Cardiac sympathetic denervation to prevent life-threatening arrhythmias. Nat. Rev. Cardiol. 11, 364–353. doi: 10.1038/nrcardio.2014.19
Schwartz, P. J., and Stone, H. L. (1980). Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation 62, 1256–1265. doi: 10.1161/01.CIR.62.6.1256
Schwartz, P. J., and Stone, H. L. (1982). Left stellectomy and denervation supersensitivity in conscious dogs. Am. J. Cardiol. 49, 1185–1190. doi: 10.1016/0002-9149(82)90043-1
Shen, M. J., and Zipes, D. P. (2014). Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ. Res. 114, 1004–1021. doi: 10.1161/CIRCRESAHA.113.302549
Stams, T. R., Oosterhoff, P., Heijdel, A., Dunnink, A., Beekman, J. D., van der Nagel, R., et al. (2016). Beat-to-beat variability in preload unmasks latent risk of Torsade de Pointes in anesthetized chronic atrioventricular block dogs. Circ. J. 80, 1336–1345. doi: 10.1253/circj.CJ-15-1335
Thomsen, M. B., Truin, M., van Opstal, J. M., Beekman, J. D., Volders, P. G., Stengl, M., et al. (2005). Sudden cardiac death in dogs with remodeled hearts is associated with larger beat-to-beat variability of repolarization. Basic Res. Cardiol. 100, 279–287. doi: 10.1007/s00395-005-0519-6
Thomsen, M. B., Verduyn, S. C., Stengl, M., Beekman, J. D. M., de Pater, G., van Opstal, J., et al. (2004). Increased short-term variability of repolarization predicts d-sotalol-induced Torsade de Pointes in dogs. Circulation 110, 2453–2459. doi: 10.1161/01.CIR.0000145162.64183.C8
Varkevisser, R., Wijers, S. C., Van der Heyden, M. A., Beekman, J. D., Meine, M., and Vos, M. A. (2012). Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. Heart Rhythm 9, 1718–1726. doi: 10.1016/j.hrthm.2012.05.016
Keywords: autonomous nervous system, heart failure, valsalva maneuver, action potential duration variability, beta-blocker, activation recovery interval
Citation: Van Weperen VYH, Vos MA and Van der Heyden MAG (2017) Commentary: Autonomic Modulation in Patients with Heart Failure Increases Beat-to-Beat Variability of Ventricular Action Potential Duration. Front. Physiol. 8:459. doi: 10.3389/fphys.2017.00459
Received: 19 May 2017; Accepted: 15 June 2017;
Published: 30 June 2017.
Edited by:
Tobias Opthof, Academic Medical Center, NetherlandsReviewed by:
Vadim V. Fedorov, The Ohio State University Columbus, United StatesCopyright © 2017 Van Weperen, Vos and Van der Heyden. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marcel A. G. Van der Heyden, m.a.g.vanderheyden@umcutrecht.nl